ScholarIQanswers from OpenAlex

Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis

PaperCitations, authors & open-access status

Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis have?

ScholarIQcitation count

Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis has 322 citations in the OpenAlex counts ScholarIQ stores.

When was Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis published?

ScholarIQyear

Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis has 2023 year in the ScholarIQ index.

What is the open-access status of Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis?

ScholarIQoa status

Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis has green oa status in the ScholarIQ index.

What is the DOI of Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis?

ScholarIQdoi

The DOI for Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis is on the source record.

What is the PMID of Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis?

ScholarIQpmid

The PMID for Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis is on the source record.

What is the OpenAlex record for Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis?

ScholarIQopenalex

The OpenAlex for Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial